Comprehensive detail of some recently used plants for the treatment of cancer
| Name of plant with family | Plant part used | Formulation type | Cell line/Animal model | Type of cancer | Reference |
|---|---|---|---|---|---|
| Malva sylvestris L. (Malvaceae) | Leaves | AgNPs | RCC-JW (KTCTL-195), RCC-GH, CaKi-2, HEK293 cell lines and HUVEC cell line | Renal cell carcinoma | [34] |
| Hedra helix (Araliaceae) | Leaves | AuNPs | MCF-7 and MDA-MB-231 | Cytotoxic activities | [35] |
| Senna alexandrina (Fabaceae) | |||||
| Thyme vulgaris (Lamiaceae) | |||||
| Tribulus terrestris (Zygophyllaceae) | |||||
| Mellissa officinalis (Lamiaceae) | Leaf | Herbal NPs | HUVEC cell line | Human lung cancer | [36] |
| Platycodon grandiflorum [Jacq.] A. DC(Campanulaceae) | Dried radix and rhizome | Lipid-polymer NPs | Mice (BALB/c) 4T1 tumor-bearing mice | Breast cancer | [37] |
| Curcuma zedoaria [Berg.] Rosc (Zingiberaceae) | |||||
| Curcuma longa (Zingiberaceae) | Rhizome | AgNPs | HT-29 cell line | Human colon cancer | [38] |
| Curcuma aromatic (Zingiberaceae) | |||||
| Curcuma caesia (Zingiberaceae) | |||||
| Rosmarinus officinalis (Lamiaceae) | Leaves | Palladium NPs, platinum NPs, bimetallic (palladium + platinum) NPs | SW480 and LS180 cell line | Human colorectal cancer | [39] |
| Ginseng (Araliaceae) | Roots | ||||
| Ammi visnaga (Apiaceae) | Entire plant | AgNPs | HeLa cell line | Anticancer activity | [40] |
| Artemisinin (Asteraceae) | Niosomal NPs | SW480 | Colorectal cancer | [41] | |
| Mangifera indica (Anacardiaceae) | Peel | AuNPs | MDA-MB-231/female mice | Breast cancer | [42] |
| Catharanthus roseus (Apocynaceae) | Leaves | AgNPs | Human liver cancer (HepG2) cells | Hepatocellular carcinoma (HCC) or liver cancer | [43] |
| Berberis thunbergii(Berberidaceae) | Leaf | AgNPs | PANC-1, AsPC-1, and MIA PaCa-2 | Human pancreatic cancer | [44] |
| Salvia miltiorrhiza (Lamiaceae) | Root | Lipid-polymer hybrid NPs | 4T1 breast cancer tumor-bearing nude mouse model | Breast cancer | [45, 46] |
AgNPs: Silver nanoparticles